OOIR: Observatory of International Research

Papers

(The H4-Index of Cellular & Molecular Immunology is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications	1126
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death	731
NLRP3 inflammasome activation and cell death	483
Tumor-infiltrating lymphocytes in the immunotherapy era	396
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies	390
The ORF3a protein of SARS-CoV-2 induces apoptosis in cells	373
Serum IgA, IgM, and IgG responses in COVID-19	362
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor	305
An update on the regulatory mechanisms of NLRP3 inflammasome activation	300
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities	291
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70	272
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity	257
Neutrophil chemoattractant receptors in health and disease: double-edged swords	251
Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients	194
Macrophages and the maintenance of homeostasis	184
Cancer immunotherapy with γδ T cells: many paths ahead of us	179
Neutrophils in chronic inflammatory diseases	178
Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses	178
The blood–brain barrier in systemic infection and inflammation	177
Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases	177
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors	175
Gut microbiome, liver immunology, and liver diseases	174
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron	166
Unique immunological profile in patients with COVID-19	161
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids	160

Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients	158
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells	154
Dendritic cell migration in inflammation and immunity	153
New insights into the evasion of host innate immunity by Mycobacterium tuberculosis	144
SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response	135
SARS-CoV-2-specific T cells in infection and vaccination	125
Metabolism of tissue macrophages in homeostasis and pathology	124
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer	115
Activation or exhaustion of CD8+ T cells in patients with COVID-19	107
Manganese salts function as potent adjuvants	106
Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients	103
High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients	102
The cutting-edge progress of immune-checkpoint blockade in lung cancer	102
Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response	102
Tumor-associated myeloid cells: diversity and therapeutic targeting	100
SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy	98
Immunological mechanisms and therapeutic targets of fatty liver diseases	97
Tertiary lymphoid structures in cancer – considerations for patient prognosis	94
SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation	93
Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases	91
Dendritic cells in cancer immunology	91
Neutralizing antibodies for the prevention and treatment of COVID-19	90
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors	90
ACOD1 in immunometabolism and disease	88
Human immunology and immunotherapy: main achievements and challenges	87
Neutrophils in liver diseases: pathogenesis and therapeutic targets	83
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods	83
Phages and their potential to modulate the microbiome and immunity	83
Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells	81
New insights into the cell- and tissue-specificity of glucocorticoid actions	81
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies	81
Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics	79
Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment	74
Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm	73
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection	73
Expansion of atypical memory B cells is a prominent feature of COVID-19	72
Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions	71
USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy	69
Immunopathobiology and therapeutic targets related to cytokines in liver diseases	69
T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant	67
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract	66